Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Intercure Ltd. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 3.80M | 3.53M | −269.9K (−7.1%) |
| Value | $4.93M | $8.92M | +$3.98M (+80.7%) |
New holders (2)
Institutions that held Intercure Ltd. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Toroso Investments, LLC | 325,741 | $882.8K | 0.02% |
| Bank of America Corp | 69,209 | $187.6K | 0.00% |
Sold out (3)
Institutions that held Intercure Ltd. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| AdvisorShares Investments LLC | 227,951 | $291.8K |
| Jamison Private Wealth Management, Inc. | 201 | $260 |
| Simplex Trading, LLC | 418 | $0 |